HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model

Antiangiogenic therapy is a promising strategy for cancer therapy. However, antiangiogenic therapy can induce intratumor hypoxia and hypoxia-inducible factor-1 (HIF-1) expression, which slows cancer progression. In our present study, we found that antiangiogenic therapy with sunitinib plus HIF-1 dim...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Tao, He, Sisi, Shen, Guobo, Wang, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838425/
https://www.ncbi.nlm.nih.gov/pubmed/26168132
http://dx.doi.org/10.3727/096504014X13983417587366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838425/
https://www.ncbi.nlm.nih.gov/pubmed/26168132
http://dx.doi.org/10.3727/096504014X13983417587366

Ejemplares similares